Targeting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cells

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|18|2715-2726

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.18, 2011-06, pp. : 2715-2726

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Module for Acute Myelogenous Leukemia Therapy: From Bench to Bedside

By  

Current Medicinal Chemistry, Vol. 14, Iss. 19, 2007-08 ,pp. : 2009-2023

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphatidylinositol 3-kinase Signaling as a Therapeutic Target for Cervical Cancer

By  

Current Cancer Drug Targets, Vol. 13, Iss. 2, 2013-02 ,pp. : 143-156

Bentham Science Publishers

Access to resources Recommend Favorite

Emergence of the Phosphoinositide 3-Kinase-Akt- Mammalian Target of Rapamycin Axis in Transforming Growth Factor-β-Induced Epithelial-Mesenchymal Transition

By  

Cells Tissues Organs, Vol. 193, Iss. 1-2, 2010-11 ,pp. : 8-22

Karger

Access to resources Recommend Favorite

Targeting the Phosphatidylinositol 3-Kinase/AKT Pathway for the Treatment of Multiple Myeloma

By  

Current Medicinal Chemistry, Vol. 21, Iss. 27, 2014-09 ,pp. : 3173-3187

Bentham Science Publishers

Access to resources Recommend Favorite

New inhibitors of the mammalian target of rapamycin signaling pathway for cancer

By Albert Sébastien   Serova Maria   Dreyer Chantal   Sablin Marie-Paule   Faivre Sandrine   Raymond Eric  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 8, 2010-08 ,pp. : 919-930

Informa Healthcare

Access to resources Recommend Favorite